BioCryst Pharmaceuticals Inc (BCRX) Insider Trading

Total insider buys:
  • $10,606,554.40
Total insider sells:
  • $40,886,919.76
Most recent insider trade:
  • June 24, 2024
Most active insider trader:
  • Thomas R Staab II
Trader NameDateTitleAmountPriceTypeTotal Value
Jan. 16, 2019VP3,046$9.27Sell$28,236.42
Jan. 14, 2019VP954$9.20Sell$8,776.80
Dec. 18, 2018CMO20,488$7.58Sell$155,299.04
Dec. 10, 2018VP4,000$9.06Sell$36,240.00
Dec. 4, 2018Insider3,922$9.45Sell$37,062.90
Nov. 30, 2018VP44,290$9.07Sell$401,710.30
Nov. 23, 2018Insider15,500$9.32Sell$144,460.00
Nov. 20, 2018VP15,470$8.55Sell$132,268.50
Nov. 20, 2018Insider11,198$8.67Sell$97,086.66
Nov. 8, 2018VP5,280$8.15Sell$43,032.00
Nov. 8, 2018Insider14,087$8.12Sell$114,386.44
Nov. 5, 2018Insider215$8.00Sell$1,720.00
Nov. 5, 2018VP100$8.00Sell$800.00
Nov. 2, 2018CFO10,856$7.84Sell$85,111.04
Nov. 1, 2018VP1,544$7.51Sell$11,595.44
Oct. 19, 2018VP100$7.50Sell$750.00
Oct. 19, 2018Insider3,150$7.45Sell$23,467.50
Oct. 3, 2018Insider9,850$7.24Sell$71,314.00
Aug. 9, 2018CMO62,500$7.03Sell$439,375.00
June 1, 2018CMO42,112$6.30Sell$265,305.60
Nov. 13, 2017CMO64,310$4.72Sell$303,543.20
Sept. 18, 2017Director54,250$5.42Sell$294,035.00
March 20, 2017CFO3,250$9.20Sell$29,900.00
March 10, 2017Insider3,250$9.06Sell$29,445.00
March 8, 2017Insider6,500$8.43Sell$54,795.00
March 6, 2017Insider3,250$7.90Sell$25,675.00
Dec. 19, 2016Insider3,250$7.45Sell$24,212.50
Sept. 14, 2016VP8,357$4.27Sell$35,684.39
Aug. 25, 2016VP30,000$4.06Sell$121,800.00
Aug. 16, 2016Major Shareholder4,046,590$5.00Sell$20,232,950.00
Aug. 12, 2016Insider5,864$5.18Sell$30,375.52
Aug. 9, 2016Insider14,577$4.43Sell$64,576.11
Jan. 28, 2016major shareholder88,345$6.95Buy$613,997.75
Jan. 22, 2016major shareholder106,800$7.28Buy$777,504.00
Jan. 20, 2016major shareholder52,695$6.87Buy$362,014.65
Jan. 19, 2016major shareholder92,200$7.12Buy$656,464.00
Jan. 15, 2016major shareholder200,000$7.46Buy$1,492,000.00
Dec. 21, 2015CFO3,052$10.86Sell$33,144.72
Dec. 17, 2015CFO3,000$10.49Sell$31,470.00
July 20, 2015CFO3,500$16.50Sell$57,750.00
June 22, 2015CFO3,750$16.00Sell$60,000.00
June 19, 2015CFO16,375$14.36Sell$235,145.00
June 19, 2015VP3,000$15.00Sell$45,000.00
June 19, 2015CEO20,000$15.02Sell$300,400.00
June 19, 2015CMO70,389$15.05Sell$1,059,354.45
June 5, 2015CFO6,000$12.75Sell$76,500.00
May 18, 2015CFO3,000$11.00Sell$33,000.00
March 19, 2015VP12,105$10.16Sell$122,986.80
March 5, 2015VP37,400$10.59Sell$396,066.00
March 4, 2015VP10,495$10.50Sell$110,197.50
  • Insiders are both buying and selling BioCryst Pharmaceuticals Inc stock.

  • The insider traders at BioCryst Pharmaceuticals Inc are: Thomas R Staab II, Lynne Powell, William P Sheridan, Alane P Barnes, Bros. Advisors Lp Baker, George B Abercrombie, Jon P Stonehouse, Yarlagadda S Babu, Anthony Doyle, Helen M Thackray, Nancy J Hutson, Steve Aselage, Machelle Sanders, Michael L Jones, Peder Jensen, Steven K Galson, Amy E Mckee, Thomas Staab II, Felix Baker, Fred E Cohen, Vincent Milano, George Abercrombie, George B. Abercrombie, Alan G Levin, Kenneth B Lee Jr, Kenneth Lee, Jr., and Megan Sniecinski

  • The most active insider trader at BioCryst Pharmaceuticals Inc is Thomas R Staab II with 35 trades.

  • Bros. Advisors Lp Baker has sold the most BioCryst Pharmaceuticals Inc stock with a total value of $40,465,900.00.

  • Felix Baker has bought the most BioCryst Pharmaceuticals Inc stock with a total value of $10,000,003.20.

  • The most recent insider trade for BioCryst Pharmaceuticals Inc was on June 24, 2024.

  • The single biggest insider buy for BioCryst Pharmaceuticals Inc was from Felix Baker with a total value of $5,000,001.60 on Aug. 1, 2013.

  • The single biggest insider sell for BioCryst Pharmaceuticals Inc was from Bros. Advisors Lp Baker with a total value of $20,232,950.00 on Aug. 16, 2016.